| Cefepime vs. Carbapenems for Treating AmpC β-lactamase-producing Enterobacteriaceae Bloodstream Infections (NCT05535751) | University Hospital, Strasbourg, France | 2022-07-20 |
| Predictors of Infective Endocarditis Among Patients Managed for Staphylococcus Aureus Bacteremia, Particularly Staphylococcus Aureus Bacteriuria, and Time to Blood Culture Positivity (NCT05522764) | Fondation Hôpital Saint-Joseph | 2022-07-18 |
| PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections (NCT05355350) | Rambam Health Care Campus | 2022-07-01 |
| Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia (NCT05184764) | Armata Pharmaceuticals, Inc. | 2022-04-26 |
| Evaluation of Bacteremia Epidemiology During the COVID Period in One French University Hospital (NCT05640349) | Centre Hospitalier Universitaire de Nice | 2022-04-15 |
| Rapid Blood Culture Identification Panel in Pediatric Patients in Guatemala (NCT05314816) | University of Colorado, Denver | 2022-04-07 |
| Epidemiology of Bacteremia at Two Tertiary ICUs in Switzerland (NCT05236283) | Insel Gruppe AG, University Hospital Bern | 2022-02-01 |
| Design of a Predictive Score for Contamination of Pediatric Blood Cultures (NCT06300736) | Central Hospital, Nancy, France | 2022-01-01 |
| Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults (NCT04882085) | Pfizer | 2021-08-26 |
| Monocyte Distribution Width (MDW) in the General Population of Emergency Department Patients With and Without Bacteremia (NCT05296590) | Henry Ford Health System | 2021-07-01 |
| Intensive Care Unit Acquired Infections in Patients Colonized With Extended Spectrum Enterobacteriaceae (NCT04903886) | University Hospital, Brest | 2021-06-01 |
| Infectious Diseases in Aged Population (NCT04825132) | University Hospital, Grenoble | 2021-04-01 |
| Continuous Temperature Telemonitoring of Patients With COVID-19 and Other Infectious Diseases in Hospital at Home Using Viture (NCT05959928) | Vitio Medical S.L. | 2021-02-09 |
| Temocillin vs Meropenem for the Targeted Treatment of Bacteraemia Resistant to Third Gen Cephalosporins (NCT04478721) | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2020-12-15 |
| Diagnostic Performance of Plasma Procalcitonin for the Detection of Blood Cultures Contaminations (NCT04573894) | Central Hospital, Nancy, France | 2020-06-01 |
| Epidemiology and Determinants of Outcomes of Hospital Acquired Blood Stream Infections in the Intensive Care in Turkey (NCT04304456) | SCARE (Study group for carbapenem resistance) | 2020-06-01 |
| Host RNA Profiles to Detect Infections in Young Infants (NCT04823026) | Rigshospitalet, Denmark | 2020-05-15 |
| Clinical Performance and Reproducibility of the Accelerate PhenoTest™ Blood Culture (BC) Kit With New Antibiotic Wave I Updates (NCT04295915) | Accelerate Diagnostics, Inc. | 2020-03-11 |
| Assessment of Assay for Rapid Identification of Bloodstream Infections From Whole Blood (NCT04147975) | HelixBind, Inc. | 2019-10-01 |
| Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex (NCT03894046) | Entasis Therapeutics | 2019-09-05 |
| Safety of Acupuncture and Intracutaneous Needles in Pediatric Cancer Patients: a Retrospective Study (ACUSAFE2021) (NCT05585463) | Fundació Sant Joan de Déu | 2019-09-01 |
| Improving Dosing of Vancomycin in Young Infants With Infections (NCT04044703) | Murdoch Childrens Research Institute | 2019-08-30 |
| Epidemiology and Determinants of Outcomes of Hospital Acquired Blood Stream Infections in the Intensive Care (NCT03937245) | Outcome Rea | 2019-08-30 |
| Fast Assay for Pathogen Identification - Quasi-Experimental Intervention Study (NCT04103203) | Hasselt University | 2019-07-01 |
| Ertapenem for Initial Empirical Treatment of Third Generation Cephalosporin Resistant Enterobacteriaceae Bacteremia (NCT03925402) | Phramongkutklao College of Medicine and Hospital | 2019-05-15 |
| Bacteremia From Periodontal Treatment to Elucidate the Underpinnings of Sepsis (NCT04565691) | Malmö University | 2019-02-25 |
| Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029) (NCT03643952) | Merck Sharp & Dohme LLC | 2018-12-06 |
| Empirical Antibiotic and Outcome in Community-onset Bacteremia (NCT03765749) | Phramongkutklao College of Medicine and Hospital | 2018-11-22 |
| Turkish Prospective Cohort Study on Carbapenem Resistant Klebsiella Pneumonia Bacteremia (NCT03597841) | Koç University | 2018-06-25 |
| Blood Culture Improvement Guidelines and Diagnostic Stewardship for Antibiotic Reduction in Critically Ill Children (NCT03441126) | Johns Hopkins University | 2018-04-01 |
| Bloodstream Infection of Carbapenem-Resistant Proteus Mirabilis (NCT06542965) | Dokuz Eylul University | 2018-01-01 |
| Impact of the Blood Culture Technique on the Diagnosis of Infective Endocarditis (NCT03153384) | Central Hospital, Nancy, France | 2017-11-11 |
| Therapeutic Drug Monitoring and Continuous Infusion of Beta-lactam Antibiotics in Patients With Bacteraemia (NCT03108690) | Sara Thønnings | 2017-10-01 |
| Amoxicillin to Prevent Bacteria and Inflammatory Biomarkers After Intensive Periodontal Therapy (NCT03354338) | Universidad El Bosque, Bogotá | 2017-09-21 |
| Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Participants With Staphylococcus Aureus Bacteremia Receiving Standard-of-Care (SOC) Antibiotics (NCT03162250) | Genentech, Inc. | 2017-07-13 |
| Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Infective Endocarditis (NCT03148756) | AbbVie | 2017-05-12 |
| Impact of Rapid Pathogen Identification From Blood Cultures (RABbIT) (NCT02743585) | Tan Tock Seng Hospital | 2017-03-20 |
| Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (NCT03005145) | Sunnybrook Health Sciences Centre | 2017-02-24 |
| C-reactive Protein Information and Blood Cultures for Emergency Department Patients With Sepsis (NCT03714841) | University of British Columbia | 2017-01-21 |
| Antibiotic "Dysbiosis" in Preterm Infants (NCT02784821) | University of Florida | 2017-01-16 |
| Daptomycin as Adjunctive Therapy for Staphylococcus Aureus Bacteremia (NCT02972983) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2016-12-01 |
| Fosfomycin I.v. for Treatment of Severely Infected Patients (NCT02979951) | Infectopharm Arzneimittel GmbH | 2016-12-01 |
| Childhood Acute Illness and Nutrition Network (NCT03208725) | University of Oxford | 2016-11-30 |
| BALANCE on the Wards: A Pilot RCT (NCT02917551) | Sunnybrook Health Sciences Centre | 2016-10-10 |
| Spanish Bacteriemia Cohort 2016: Epidemiology, Clinical Management and Prognosis Factors (NCT03148769) | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2016-10-01 |
| Diagnosis of Bacteremia/Septicemia and Culture Negative Endocarditis by the Karius Sequencing-Based Infectious Disease Diagnostic Assay (NCT02988414) | Karius, Inc. | 2016-07-01 |
| Safety Evaluation of Seraph® 100 to Reduce Bacteremia in Patients on Hemodialysis (NCT02914132) | ExThera Medical Corporation | 2016-02-01 |
| Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study. (NCT02852902) | Spanish Network for Research in Infectious Diseases | 2016-01-01 |
| Preventing Catheter-related Bacteremia When Administering Injectable Medications in Premature Infants. (NCT02633124) | University Hospital, Lille | 2016-01-01 |
| Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture (NCT02719769) | Accelerate Diagnostics, Inc. | 2016-01-01 |
| T2Bacteria Panel Pivotal Study (NCT02535468) | T2 Biosystems | 2015-12-01 |
| IL-10 Stratifying Tool for Towards Antibiotic Selection for MRSaB (NCT02660346) | Sharp HealthCare | 2015-11-01 |
| Effect of Supplementation of Fluoride on Maternal Periodontal Health, Preterm Delivery, and Perinatal Well-Being (NCT02536352) | Johns Hopkins University | 2015-10-01 |
| Factors Associated With Increased Risk of Bacteremia and Cholangitis in ERCP With Cholangioscopy (NCT02543957) | Baylor College of Medicine | 2015-09-01 |
| Ultra Rapid Culture Independent Detection of High-Priority Carbapenem Resistant Enterobacteriaceae Directly From Blood (NCT02482051) | Denver Health and Hospital Authority | 2015-07-01 |
| Procalcitonin Levels as a Predictor of Bacteremia in Febrile Pediatric Oncology Patients-Pilot Study (NCT02417168) | CAMC Health System | 2015-07-01 |
| Home Away From Home - Medical Outcomes (NCT02774850) | Children's Hospital of Philadelphia | 2015-06-01 |
| Randomized-controlled Trial (RCT) on Combination Antibiotic for Infections Caused by Gram-negative Bacteria (NCT02134106) | Tan Tock Seng Hospital | 2015-01-01 |
| A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial (NCT02208063) | Cumberland Pharmaceuticals | 2014-12-01 |
| Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness: A Pilot RCT (NCT02261506) | Sunnybrook Health Sciences Centre | 2014-10-16 |
| RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates (NCT02210169) | Murdoch Childrens Research Institute | 2014-09-01 |
| Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults (NCT02168946) | Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) | 2014-07-01 |
| Study of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae (NCT02420366) | Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) | 2014-05-01 |
| Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic Shock (NCT01867905) | University of British Columbia | 2014-03-01 |
| Prospective Study to Characterize Host-pathogen Related Factors in Hospitalized and ED Patients With LRTI and/or Sepsis (NCT02025699) | MeMed Diagnostics Ltd. | 2014-02-01 |
| A New Antibiotic Prophylaxis Regimen to Prevent Bacteremia Following Dental Procedures (NCT02115776) | University of Santiago de Compostela | 2014-01-01 |
| Virulence of Staphylococcus Lugdunensis in Severe Infections (NCT02026895) | University Hospital, Strasbourg, France | 2013-12-01 |
| Rapid Identification and Susceptibility Testing of Pathogens From Blood Cultures (NCT01898208) | Mayo Clinic | 2013-08-01 |
| Detecting Infections Rapidly and Easily for Bacteremia Trial (DIREBT) (NCT01919762) | T2 Biosystems | 2013-08-01 |
| Simplified Selective Digestive Tract Decontamination for the Prevention of Intensive Care Unit Acquired Infections (NCT01798537) | Rambam Health Care Campus | 2013-06-01 |
| Vancomycin Versus Ceftaroline in Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline (NCT01724671) | CPL Associates | 2012-12-01 |
| Safety & Efficacy of Daptomycin Versus Standard of Care (SOC) in 1 - 17 Year Olds With Staphylococcus Aureus Bacteremia (MK-3009-005) (NCT01728376) | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2012-11-29 |
| Immune Response of Patients With Chronic, Staphylococcus Aureus-infected Wounds (NCT01551667) | Centre Hospitalier Universitaire de Nīmes | 2012-11-01 |
| Blood Cultures's Profitability in Intensive Care Unit (NCT02869191) | Hospital Universitario Getafe | 2012-10-01 |
| Study of the Performance of the KeyPath MRSA/MSSA Blood Culture Test - BTA (NCT01640886) | MicroPhage, Inc. | 2012-06-01 |
| Concentration of Antimicrobials in Catheter-lock Solutions (NCT01592032) | Clinica Universidad de Navarra, Universidad de Navarra | 2012-05-01 |
| Hub Cleansing to Prevent Hub Infection (NCT01563406) | Rush University Medical Center | 2012-03-01 |
| Efficacy of 2% Chlorhexidine Gluconate in 70% Alcohol Compare 10% Povidone Iodine in Blood Culture in Children (NCT01919593) | Thammasat University | 2012-01-01 |
| Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients (NCT01734694) | Henry Ford Health System | 2011-10-01 |
| Efficacy and Safety of an Ethanol/Sodium Citrate Locking Solution: A Pilot Study (NCT01394458) | University of Manitoba | 2011-08-01 |
| Recurrent ESBL-producing Enterobacteriaceae Bacteremia: Risk Factor, Molecular Character and Susceptibility Change (NCT01392118) | Chang Gung Memorial Hospital | 2011-07-01 |
| Vancomycin Versus Daptomycin for the Treatment of Methicillin-resistant Staphylococcus Aureus Bacteremia Due to Isolates With High Vancomycin Minimum Inhibitory Concentrations (MICs) (NCT01287832) | St. John Health System, Michigan | 2011-06-01 |
| Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer Patients (NCT01321879) | M.D. Anderson Cancer Center | 2011-03-01 |
| Retrospective Evaluation of Safety and Efficacy of Daptomycin Used in Patients With Serious Gram-positive Infections (NCT01301638) | Far Eastern Memorial Hospital | 2011-02-01 |
| Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection (NCT01191840) | Duke University | 2011-02-01 |
| Comparison of Nephrotoxicity and Hospital Costs in Patients With Methicillin-Resistant Staphylococcus Aureus Bacteremia Who Received Vancomycin Versus Teicoplanin Therapy (NCT01352936) | Taipei Medical University WanFang Hospital | 2011-01-01 |
| Epidemiologic Patterns of Bacteremia After Trauma (NCT04042636) | Asan Medical Center | 2011-01-01 |
| Bacteraemia Secondary to Tooth Extraction: Chlorhexidine Prophylaxis Protocols (NCT02150031) | University of Santiago de Compostela | 2010-12-01 |
| Establish Quantitative PCR to Measure Bacteria Load of the VRE Bacteremia (NCT01265095) | National Taiwan University Hospital | 2010-12-01 |
| Clinical Evaluation of Novel Biomarkers in Patients With Septicemia (NCT01359891) | Medical University of Graz | 2010-11-01 |
| Incidence of Bacteremia Following Argon Plasma Coagulation in Patients With Endobronchial Lesions (NCT01179022) | Meir Medical Center | 2010-10-01 |
| Ethanol Lock for the Salvage of Infected Long-term Vascular Access (NCT01186172) | Fondazione IRCCS Policlinico San Matteo di Pavia | 2010-06-01 |
| Safety and Efficacy Study of Ethanol Locking to Prevent Central Line Infection in Premature Neonates (NCT01365312) | East Carolina University | 2010-02-01 |
| Daptomycin Pharmacokinetics in Continuous Veno-venous Hemodiafiltration (NCT01171547) | University of Zurich | 2010-02-01 |
| Increasing the Yield of Blood Cultures in Neonates (NCT01023555) | Shaare Zedek Medical Center | 2010-01-01 |
| Comparison of Infection Rates Among Patients Using Two Catheter Access Devices (NCT00965198) | Emory University | 2009-11-01 |
| Prospective Study Into the Performance of the MicroPhage S. Aureus/MSSA/MRSA Test Direct From Blood Culture Positives (NCT01184339) | MicroPhage, Inc. | 2009-08-01 |
| Prevalence of CVC-associated Sepsis and Use of Blood Cultures in Berlin - Brandenburg (NCT01388686) | Charite University, Berlin, Germany | 2009-08-01 |
| Central Venous Catheter Lock Solution (NCT00862966) | University Medical Center, Tuzla | 2009-04-01 |
| Effectiveness of Routine Sterile Gloving in Blood Culture (NCT00973063) | Seoul National University Hospital | 2009-03-01 |